Amgen Undergrad Intern - Process Development Drug Product in Puerto Rico, Puerto Rico
Amgen is looking for self-motivated individuals, with strong analytical skills, decision-making, and leadership attributes, willing to join a Biotechnology World Class Company under our University Relations Program.
The Undergrad-Intern will apply the skills learned at the university in the pharmaceutical industry and learn new ones from hands on experience of work assignment. Key skills include but are not limited to: communication, planning, organization, problem solving, team-working, data monitoring etc.
This position is based in Juncos, Puerto Rico for Drug Product - Process Development department. Amgen Manufacturing Limited is chosen one of the top 3 Best Employers in Puerto Rico. The selected candidate will start in May 2019.
Specific responsibilities include but are not limited to:
Evaluation of the historical and current data
Define/develop standard works (protocols/procedures) for specific tasks
Prepare project justification
Meeting coordination with interdepartmental groups for agreement on path forward
Identify efficiency opportunities
Communicate with people in diverse language ability, educational levels and experiences
At least 3.00 GPA (General)
Be in the process of earning a bachelor’s degree in Biomedical Engineering
Be enrolled in university
All individuals applying for an internship or a co-op assignment at Amgen need to meet the following criteria:
Have not graduated yet
Be pursuing an applicable degree or course of study
Be enroll in school under a Coop program
Strong technical writing skills
Good interpersonal skills
Able to work with minimum supervision
Meet milestones and deliver high quality results
Enthusiastic about learning new concepts and work processes
Proficient in the following software: MS Excel, MS Word, MS Power Point
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.